Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis
Shiru Cai, Shenglong Xu, Hongfei Lou, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 7, pp. 1876-1886.e7
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis
Giacomo Emmi, Alessandra Bettiol, Elena Gelain, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 6, pp. 378-393
Open Access | Times Cited: 134
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management
William Shomali, Jason Gotlib
American Journal of Hematology (2024) Vol. 99, Iss. 5, pp. 946-968
Open Access | Times Cited: 16
Real‐World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps
Marisa Dorling, Juan Carlos Hernaiz‐Leonardo, Athenea Pascual, et al.
The Laryngoscope (2024) Vol. 134, Iss. 7, pp. 3054-3059
Open Access | Times Cited: 14
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access | Times Cited: 1
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps
Mu Xian, Bing Yan, Xicheng Song, et al.
Allergy (2025)
Open Access | Times Cited: 1
Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial
Yuan Zhang, Bing Yan, Shen Shen, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102076-102076
Open Access | Times Cited: 22
Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy
George Papacharalampous, Jannis Constantinidis, G. Fotiadis, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 21
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP)
Emily Garvey, Bita Naimi, Alexander Duffy, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 3, pp. 651-659
Open Access | Times Cited: 12
Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study
Juan M. Solano, M. Amparo Callejón, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 10, pp. 555-566
Closed Access | Times Cited: 12
A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012–2022
Robert M. Naclerio, Joaquim Mullol, Whitney W. Stevens
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 1, pp. 43-50
Closed Access | Times Cited: 11
Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study
Shen Shen, Bing Yan, Ming Wang, et al.
Asia Pacific Allergy (2024) Vol. 14, Iss. 3, pp. 118-123
Open Access | Times Cited: 4
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps
Angélica Tiotiu, Nicolas Migueres, Francisco Javier González‐Barcala, et al.
Respiratory Medicine (2025) Vol. 238, pp. 107979-107979
Closed Access
Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps
Anju T. Peters, Xiaohui Zhao, Aimee M. Near, et al.
Advances in Therapy (2025)
Open Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Long-term efficacy and safety of different biologics in treatment of chronic rhinosinusitis with nasal polyps: A network meta-analysis
Han Chen, Lin Wang, Jisheng Zhang, et al.
Brazilian Journal of Otorhinolaryngology (2025) Vol. 91, Iss. 4, pp. 101633-101633
Closed Access
Biological Treatment for Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: Preliminary Real-World Results from a Tertiary Medical Center
Reut Book, Shalom Eligal, Yuval Tal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3671-3671
Open Access | Times Cited: 10
Biologics and Hypereosinophilic Syndromes: Knowledge Gaps and Controversies
Fei Li Kuang, Paneez Khoury, Peter F. Weller, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2666-2671
Closed Access | Times Cited: 10
Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review
Sara Munari, Giulia Ciotti, Walter Cestaro, et al.
Drugs in Context (2024) Vol. 13, pp. 1-11
Open Access | Times Cited: 3
Switching biologics in chronic rhinosinusitis with nasal polyps: A multicenter Canadian experience
Marisa Dorling, Masih Sarafan, Béatrice Voizard, et al.
International Forum of Allergy & Rhinology (2024) Vol. 15, Iss. 2, pp. 166-173
Open Access | Times Cited: 3
Therapeutical Targets in Allergic Inflammation
Lorenzo Salvati, Francesco Liotta, Francesco Annunziato, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2874-2874
Open Access | Times Cited: 11
Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
Neal R. Godse, Anjeni Keswani, Andrew P. Lane, et al.
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 207-213
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top